Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Leinonen (Liestal, Switzerland). Meta-analysis of two clinical trials: Slowing respiratory decline in Duchenne muscular dystrophy (DMD). 1043

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of Idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): Comparison of analysis methods Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017 Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD) Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Which are the most informative parameters to follow the respiratory decline in Duchenne muscular dystrophy? Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children Year: 2012 Home-based versus hospital monitoring of respiratory function changes in Duchenne muscular dystrophy (DMD) Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction Year: 2018 Observation cohort study of cause of death in patients with Duchenne muscular dystrophy (DMD) Source: Annual Congress 2012 - Current trends in home mechanical ventilation Year: 2012 Respiratory kinematics in Duchenne muscular dystrophy (DMD) Source: Eur Respir J 2007; 30: Suppl. 51, 376s Year: 2007 Sleep in patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA): is there a difference? Source: Eur Respir J 2001; 18: Suppl. 33, 88s Year: 2001 Effects of idebenone on pulmonary morbidity in Duchenne muscular dystrophy (DMD) Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017 Inefficient cough in Duchenne muscular dystrophy (DMD) Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children Year: 2012 Respiratory muscle testing: a valuable tool for young patients with Duchenne muscular dystrophy Source: Eur Respir J 2006; 28: Suppl. 50, 357s Year: 2006 The natural course of lung volumes in Duchenne Muscular Dystrophy (DMD) Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children Year: 2017 Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood Source: Eur Respir J, 51 (2) 1701418; 10.1183/13993003.01418-2017 Year: 2018 Thoraco-abdominal asynchronies during spontaneous breathing in Duchenne muscular dystrophy (DMD) Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children Year: 2012 Assessment of diaphragm thickness variations by ultrasonography in patients with Duchenne muscular dystrophy (DMD) Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children Year: 2012 Implication of regular pulmonary function evaluation in Duchenne muscular dystrophy Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease Year: 2020 Long term efficacy: Idebenone reduces the rate of both inspiratory and expiratory functional loss in Duchenne muscular dystrophy (DMD) Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives Year: 2019 Ventilatory assistance in patients with Duchenne muscular dystrophy Source: Eur Respir J 2006; 28: 468-469 Year: 2006 Gastrointestinal dysfunction in ventilated patients with Duchenne muscular dystrophy Source: Annual Congress 2012 - Current trends in home mechanical ventilation Year: 2012 Evolution of pulmonary function in children with Duchenne muscular dystrophy: implication of expiratory muscles Source: Eur Respir J 2005; 26: Suppl. 49, 499s Year: 2005 Nutritional status and admission risk in Duchenne muscular dystrophy (DMD) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013